FindTrial
Sign In

Effect of growth hormone on the outcome of IVF-ET in PCOS patients

Effect of growth hormone on the outcome of IVF-ET in PCOS patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027647
Enrollment
Unknown
Registered
2019-11-22
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Group 1:GH pretreatment
Group 2:No GH pretreatment

Sponsors

Women and Children's Hospital of Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Body mass index (BMI) 18.5 to 28kg/m2; 2. Aged <=35 years old; 3. The indication of pregnancy assistance is PCOS, and the factors of PCOS complicated with fallopian tubes; 4. All were the first COH cycle

Exclusion criteria

Exclusion criteria: 1. Severe oligospermia for male; 2. Previous ovarian surgery, congenital uterine malformation, endometriosis, adenomyosis, uterine cavity adhesion, etc 3. Accompanied by other endocrine diseases, such as hyperprolacemia, abnormal thyroid function, diabetes, etc.

Design outcomes

Primary

MeasureTime frame
Number of eggs harvested;—

Countries

China

Contacts

Public ContactLi Ping

Women and Children's Hospital of Xiamen University

daring@stu.xmu.edu.cn+86 13950078214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026